# reload+after+2024-01-21 11:44:38.715811
address1§Essener Bogen 7
city§Hamburg
zip§22419
country§Germany
phone§49 40 560 81 0
fax§49 40 560 81 222
website§https://www.evotec.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals, as well as a strategic partnership with Dewpoint Therapeutics to advance oncology pipeline programs of condensate modifying therapeutics to investigational new drug applications and a licensing agreement with Glycotope GmbH to develop next generation immune cell engaging bispecifics for various potential indications, including solid tumors The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.
fullTimeEmployees§5086
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Werner  Lanthaler M.B.A., MPA, Ph.D.', 'age': 55, 'title': 'Chairman of Management Board & CEO', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 1445096, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Cord  Dohrmann Ph.D.', 'age': 59, 'title': 'Chief Scientific Officer & Member of Management Board', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 880862, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Craig  Johnstone Ph.D.', 'age': 53, 'title': 'COO & Member of Management Board', 'yearBorn': 1970, 'fiscalYear': 2022, 'totalPay': 780067, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Matthias  Evers Ph.D.', 'age': 50, 'title': 'Chief Business Officer & Member of Management Board', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 696802, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Laetitia  Rouxel', 'age': 49, 'title': 'CFO & Member of Management Board', 'yearBorn': 1974, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Anja  Bosler', 'title': 'Principal Accounting Officer and Senior Vice President of Group Accounting', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Volker  Braun', 'title': 'Senior VP and Global Head of Investor Relations & ESG', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Christian  Dargel', 'title': 'EVP Global Head of Legal & Compliance', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Gabriele  Hansen', 'title': 'Senior VP & Head of Global Corporate Communications & Marketing', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Monika  Conradt', 'title': 'Global Head of Human Resources', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§3
boardRisk§2
compensationRisk§7
shareHolderRightsRisk§1
overallRisk§4
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.128
priceToSalesTrailing12Months§4.207282
currency§USD
dateShortInterest§1702598400
forwardEps§0.17
pegRatio§-0.09
exchange§NMS
quoteType§EQUITY
shortName§Evotec SE
longName§Evotec SE
firstTradeDateEpochUtc§1075991400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§d38f92ff-a363-3ec4-a23c-74ec13c26d06
gmtOffSetMilliseconds§-18000000
targetHighPrice§21.0
targetLowPrice§13.0
targetMeanPrice§16.3
targetMedianPrice§15.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§5
quickRatio§1.919
grossMargins§0.26784
ebitdaMargins§0.11858
trailingPegRatio§None
